Zhejiang Dayang Biotech Group Co (003017) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Dayang Biotech Group Co (003017) has a cash flow conversion efficiency ratio of 0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥638.25K ≈ $93.40K USD) by net assets (CN¥1.10 Billion ≈ $161.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 003017 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Zhejiang Dayang Biotech Group Co - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Zhejiang Dayang Biotech Group Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Zhejiang Dayang Biotech Group Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Dayang Biotech Group Co ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Ecobeauty Co Ltd
SHE:000010
|
0.086x |
|
Rossari Biotech Limited
NSE:ROSSARI
|
0.024x |
|
Materialise NV
NASDAQ:MTLS
|
0.027x |
|
Rotshtein
TA:ROTS
|
-0.082x |
|
Alandsbanken Abp A
HE:ALBAV
|
0.054x |
|
Formosan Union Chemical Corp
TW:1709
|
0.023x |
|
Stalprodukt SA
WAR:STP
|
-0.026x |
|
PARKEN Sport & Entertainment
CO:PARKEN
|
0.252x |
Annual Cash Flow Conversion Efficiency for Zhejiang Dayang Biotech Group Co (2013–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Dayang Biotech Group Co from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Zhejiang Dayang Biotech Group Co (003017) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.14 Billion ≈ $166.34 Million |
CN¥160.11 Million ≈ $23.43 Million |
0.141x | +124.09% |
| 2024-12-31 | CN¥1.05 Billion ≈ $154.11 Million |
CN¥66.19 Million ≈ $9.69 Million |
0.063x | -65.26% |
| 2023-12-31 | CN¥1.01 Billion ≈ $147.53 Million |
CN¥182.42 Million ≈ $26.69 Million |
0.181x | +93.97% |
| 2022-12-31 | CN¥985.05 Million ≈ $144.14 Million |
CN¥91.89 Million ≈ $13.45 Million |
0.093x | +362.87% |
| 2021-12-31 | CN¥990.71 Million ≈ $144.97 Million |
CN¥-35.16 Million ≈ $-5.14 Million |
-0.035x | -130.23% |
| 2020-12-31 | CN¥958.13 Million ≈ $140.20 Million |
CN¥112.49 Million ≈ $16.46 Million |
0.117x | -48.29% |
| 2019-12-31 | CN¥498.09 Million ≈ $72.89 Million |
CN¥113.09 Million ≈ $16.55 Million |
0.227x | +158.02% |
| 2018-12-31 | CN¥440.62 Million ≈ $64.48 Million |
CN¥38.77 Million ≈ $5.67 Million |
0.088x | -38.90% |
| 2017-12-31 | CN¥337.71 Million ≈ $49.42 Million |
CN¥48.64 Million ≈ $7.12 Million |
0.144x | -60.97% |
| 2016-12-31 | CN¥229.35 Million ≈ $33.56 Million |
CN¥84.63 Million ≈ $12.38 Million |
0.369x | +58.13% |
| 2015-12-31 | CN¥209.76 Million ≈ $30.70 Million |
CN¥48.95 Million ≈ $7.16 Million |
0.233x | -20.42% |
| 2014-12-31 | CN¥196.87 Million ≈ $28.81 Million |
CN¥57.73 Million ≈ $8.45 Million |
0.293x | -40.03% |
| 2013-12-31 | CN¥187.42 Million ≈ $27.43 Million |
CN¥91.64 Million ≈ $13.41 Million |
0.489x | -- |
About Zhejiang Dayang Biotech Group Co
Zhe Jiang Dayang Biotech Group Co., Ltd. operates as a chemical raw material manufacturing company in China and internationally. The company offers inorganic chemicals, including potassium carbonate and chloride, ammonium chloride, and bicarbonate food and feed additives; industrial grade potassium carbonate and bicarbonate; and agricultural and industrial grade ammonium chloride. It also provide… Read more